The development of composition and technology for the capsulated drug based on bee pollen and honey powder. Announcement 3.

Authors

  • B. Т. Kudrik National University of Pharmacy,
  • A. I. Тikhonov National University of Pharmacy,
  • О. S. Shpychak National University of Pharmacy,

DOI:

https://doi.org/10.14739/2409-2932.2016.3.77930

Keywords:

Ambrosia, Honey, Powder, Excipients, Technology, «Api-Immuno-Vit» Capsules, Immunomodulation

Abstract

Aim. To develop experimentally and to substantiate theoretically both in pharmaceutical and industrial conditions the technology of manufacturing for capsules with the immunomodulatory action (provisional name «Api-Immuno-Vit») basing on pharmacotechnological and physical-chemical studies. Also to study the effect of excipients, the residual moisture and the particle size of capsules on technological parameters of mixtures quality, as well as to substantiate the choice of the size for solid gelatin capsules.

Material and methods. The study objects were the experimental samples of the mixtures of «Api-Immuno-Vit» capsules with such active pharmaceutical ingredients (API) as bee pollen (DSTU 7074:2009, GOST 31776-2012) and honey powder (TU U 10.8-39834691-001:2015, as well as aerosil and mannitol, which were used as excipients.

Results. The pharmacotechnological tests of the experimental samples of the mixtures (particle size distribution, moisture content, fluidity, bulk density and tapped density, angle of repose, uniformity of mixing) were carried out using the conventional methods given in the State Pharmacopoeia of Ukraine.

The influence of particle size distribution of the granulate on technological parameters of the mixture quality in capsules has been studied. It has been found that the increase of residual moisture leads to decrease of fluidity, and therefore, the residual moisture of the mixture for encapsulation should be less than 1.5%. It has been also noted that during the experiment the presence of large and medium fractions is important for the particle size distribution since fluidity and the bulk density of the mixtures significantly reduce if the fine fraction in more than 30% in amount.

Сonclusions. The results of the experimental studies were used in developing the flowchart of «Api-Immuno-Vit» capsules manufacturing. Taking into account the physical-chemical properties and the pharmacotechnological tests the flowchart of manufacturing has been developed; the technological parameters of its manufacturing have been substantiated. The rational amount of excipients (moisturizers, antifriction substances, powdering agents), which are necessary for performing each technological stage, the sequence of their mixing, as well as the parameters affecting the quality and stability of the drug have been calculated, and the technology of «Api-Immuno-Vit» capsules has been tested in pharmacy and industrial conditions.

References

Obluchinskaya, E. D. (2009). Optimizaciya sostava i tekhnologii kapsul, soderzhashchikh sukhoj e´kstrakt fukusa [Optimizing the composition and technology of capsules containing dry focus extract]. Khimiko-farmacevticheskij zhurnal, 6(43), 22–26. [in Russian].

Nikolaichuk, N. O., Hladukh, Ye. V. (2008). Tekhnolohichni aspekty stvorennia kapsul na osnovi DYBAMKU [Technological aspects of creation of capsules on the basis of dibamk]. Ukrainskyi medychnyi almanakh, 11(4), 110–112. [in Ukrainian].

Alekseyev, K. V., Blynskaya, Ye. V., Suldin, A. S., Sizyakov, S. A., Alekseyeva, S. K., Zakusov, A. G., & Ditkovskaya, V. V. (2009). Vspomogatel'nye veshchestva v tekhnologii tverdykh kapsul [Excipients in the technology of hard capsules]. Farmaciya, 5, 31–36. [in Russian].

Swarbrick, J. (Ed) (2007). Encyclopedia of pharmaceutical technology. New York: Informa Healthcare USA.

Niazi, S. K. (2009) Handbook of Pharmaceutical Manufacturing Formulations. New York: Informa Healthcare, (Vol. 1).

Ofner, C. M., & Klech-Gelotte, C. M. (2002). Gels and jellies. Encyclopedia of Pharmaceutical Tehnology, J. Swarbrick, J. C. Boylan (Eds.), (P. 1327–1344). New York; Basel: Marsel Dekker.

William, A. (2008). Pharmaceutical Manufacturing Encyclopaedia. New York: William Andrew Publishing.

Sharykina, N. I. (Ed) (2013). Derzhavnyi reiestr likarskykh zasobiv Ukrainy [State register of medicines Ukraine]. Kyiv. Retrieved from http://www.drlz.kiev.ua. [in Ukrainian].

Kovalenko, V. N. (Ed) (2015) Kompendium 2015 – lekarstvennye preparaty [Compendium 2015 – drugs]. Kyiv: MORION. [in Ukrainian].

(2011). Rx-index™ – klasyfikator likarskykh preparativ [Rx–index™ – Classification of drugs] Kyiv: Farmatsevt-praktyk. [in Ukrainian].

Shpychak, О. S., & Tikhonov, O. I. (2014). Substantiation of the choice of excipients when developing the composition of «Apised» capsules. Vicnyk farmatsii, 4(80), 43–48. [in Ukrainian].

Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv». (2015). Derzhavna Farmakopeia Ukrainy [State Pharmacopoeia of Ukraine], (Vol. 1). Kharkiv. [in Ukrainian].

(1990). Hosudarstvennaya farmakopeya SSSR [State Pharmacopoeia of the USSR], (Iss. 2: Obshchye metody analyza). Moscow: Medicina. [in Russian].

(2016). Standart «Nastanova «Vymohy do vyhotovlennia nesterylnykh likarskykh zasobiv v umovakh aptek. ST-N MOZU 42-4.5:2015» [The standard "guidance" Requirements for the manufacture of sterile medicines in pharmacy. ST-H Ministry of Health 42-4.5: 2015"]. Kyiv: Ministerstvo okhorony zdorovia Ukrayiny. [in Ukrainian].

Downloads

How to Cite

1.
Kudrik BТ, Тikhonov AI, Shpychak ОS. The development of composition and technology for the capsulated drug based on bee pollen and honey powder. Announcement 3. Current issues in pharmacy and medicine: science and practice [Internet]. 2016Sep.22 [cited 2024Dec.29];9(3). Available from: http://pharmed.zsmu.edu.ua/article/view/77930

Issue

No. 3 (2016)

Section

Pharmaceutical manufacturing

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)